3 Top Stocks That Warren Buffett Bought During The Recent Quarter

Warren Buffett is one of the most trusted investors on the market. When he moves his big money, the whole street is watching and tries to figure out what he is thinking about.

The latest big move was reasonable to Exxon Mobil, the largest U.S. oil producer. Warren bought ConocoPhillips on the peak of the oil price and was wrong with his investment decision. Now it looks that he gives his oil bet a second chance with the strongest cash flow producer in this field.

At the same time Warren Buffett reduced its current position in ConocoPhillips but keeps the downstream business Philips 66 stable. I have no idea what he is thinking about with this transaction.

In addition, Warren increased shares of DaVita Healthcare Partners and Goldman Sachs. Here you can find a detailed overview about the latest big stock purchases from Warren Buffett.

Warren Buffett's latest stock purchases (click to enlarge)
Source: Gurufocus.com

Exxon Mobil (NYSE:XOM) has a market capitalization of $415.45 billion. The company employs 76,900 people, generates revenue of $453.123 billion and has a net income of $47.681 billion. Exxon Mobil’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $65.769 billion. The EBITDA margin is 14.51 percent (the operating margin is 11.01 percent and the net profit margin 10.52 percent).

Financial Analysis: The total debt represents 3.47 percent of Exxon Mobil’s assets and the total debt in relation to the equity amounts to 6.98 percent. Due to the financial situation, a return on equity of 28.03 percent was realized by Exxon Mobil. Twelve trailing months earnings per share reached a value of $7.65. Last fiscal year, Exxon Mobil paid $2.18 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 12.43, the P/S ratio is 0.92 and the P/B ratio is finally 2.58. The dividend yield amounts to 2.65 percent and the beta ratio has a value of 0.69.

Long-Term Stock Price Chart Of Exxon Mobil (XOM)

Long-Term Dividend Payment History of Exxon Mobil (XOM)

Long-Term Dividend Yield History of Exxon Mobil (XOM)

Goldman Sachs (NYSE:GS) has a market capitalization of $76.86 billion. The company employs 31,700 people, generates revenue of $41.664 billion and has a net income of $7.475 billion. Goldman Sachs’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $12.462 billion. The EBITDA margin is 29.91 percent (the operating margin is 26.90 percent and the net profit margin 17.94 percent).

Financial Analysis: The total debt represents 47.24 percent of Goldman Sachs’s assets and the total debt in relation to the equity amounts to 585.58 percent. Due to the financial situation, a return on equity of 10.66 percent was realized by Goldman Sachs. Twelve trailing months earnings per share reached a value of $16.47. Last fiscal year, Goldman Sachs paid $1.77 in the form of dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 10.29, the P/S ratio is 1.84 and the P/B ratio is finally 1.13. The dividend yield amounts to 1.30 percent and the beta ratio has a value of 1.30.

Long-Term Stock Price Chart Of Goldman Sachs (GS)

Long-Term Dividend Payment History of Goldman Sachs (GS)

Long-Term Dividend Yield History of Goldman Sachs (GS)

DaVita HealthCare Partners (NYSE:DVA) has a market capitalization of $13.09 billion. The company employs 53,400 people, generates revenue of $8.186 billion and has a net income of $641.46 million. DaVita HealthCare Partners’s earnings before interest, taxes, depreciation and amortization (EBITDA) amounts to $1,710.45 million. The EBITDA margin is 20.89 percent (the operating margin is 15.84 percent and the net profit margin 7.84 percent).

Financial Analysis: The total debt represents 53.45 percent of DaVita HealthCare Partners’s assets and the total debt in relation to the equity amounts to 227.32 percent. Due to the financial situation, a return on equity of 18.16 percent was realized by DaVita HealthCare Partners. Twelve trailing months earnings per share reached a value of $2.66. Last fiscal year, DaVita HealthCare Partners paid no dividends to shareholders.

Market Valuation: Here are the price ratios of the company: The P/E ratio is 23.18, the P/S ratio is 1.60 and the P/B ratio is finally 3.45. The beta ratio has a value of 0.49.